Please login to the form below
Vertex hits sweet spot with triple cystic fibrosis therapy
The new treatment could benefit up to 90% of patients with CF
Spark closes on first US gene therapy approval
FDA starts review of Luxturna for patients with inherited retinal disease
Amgen aspires to new Kyprolis label in the US and Europe
Appeals to regulators to add survival data to multiple myeloma drug's labelling
Sanofi to pay $750m for vaccines biotech Protein Sciences
Adds US firm's recombinant-based influenza vaccine to its portfolio
FDA halts third Merck myeloma trial after patient deaths
More patients died on Keytruda combination than those on other treatments
Opdivo tops Yervoy in adjuvant melanoma trial
BMS’ nivolumab reduced the recurrence rate of melanoma compared to Yervoy
Daiichi drug hits mark in shingles pain, but misses in other indications
ALDAY trial shows mirogabalin was unable to reduce pain for fibromyalgia patients
AZ takes Chi-Med’s kidney cancer drug into phase III
SAVOIR trial will compare Chi-Med’s savolitinib to Pfizer’s Sutent
GSK starts trial of Nucala to seek alternate indications
Asthma therapy drug to be used to target severe nasal polyposis
Riding the wave of digital disruption
The challenges and rewards of meeting consumer expectations
-
Real-world evidenceCompanies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future
-
The future of biotechWhat impact will the sector, and its R&D performance, have on pharma?
-
Alzheon says data backs potential of Alzheimer's candidateUS biotech points to new analysis of phase III results for tramiprosate
-
CV data sets up Novartis' Ilaris for blockbuster salesDrug shown to reduce major adverse cardiovascular events
-
Clovis rockets on maintenance data in ovarian cancerThe US company plans to file ARIEL3 to the FDA within a few months
-
Woodford investment pushes Dementia Discovery Fund to £100mFund aims to back 40 projects over its 15-year term
-
Medicxi aims to plug funding gap for European biotechFund also backed by Novartis, Alphabet’s Verily unit and the EIF
-
Merck suspends two Keytruda trials after patient deathsInvestigators to look at Keytruda with Pomalyst and Revlimid
-
Trial of J&J's canagliflozin boosts SGLT2 cardiovascular credentialsInvokana cuts risk of heart failure hospitalisation by a third
-
NDA bolsters its senior teamHires Eva Lilienberg, Christine Chirdo and Barbara Clendenen
-
PharmaLex appoints Zabin Younes as associate director
She joins from ERA Consulting
-
Nova appoints Richard Limb as head of quality assuranceHe joins the privately-owned company from Pfizer
-
GW Pharmaceuticals strengthens research and development teamAppoints Dr Volker Knappertz and Professor Ben Whalley
-
Kymab appoints its first chief medical officerDr Sonia Quaratino joins the firm from Novartis
Latest research appointments
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
*PROJECT MANAGER/ ACCOUNT MANAGER*
-
Competitive Salary Offered
-
*ACCOUNT MANAGER*
-
Competitive Salary Offered
-
*Middleweight Copywriter*
-
Competitive Salary
- Group Account Director, Healthcare Advertising/ Brand Comms, Lon...
-
Substantiel Package
-
Principal Medical Writer
-
Great salary and benefits
- Senior Medical Writer, Medical Communications Agency
-
£40, 000 - £45, 000 benefits
- Senior Account Manager, highly regarded Medical Communications a...
-
Excellent Package
- (Senior) Account Manager - Medical Education
-
32 - 45, 000 D.O.E
- Director of Rare Diseases, Healthcare Agency, London
-
Excellent Package
- Group Account Director or Client Services Director – Healthcare ...
-
£80, 000 – £110, 000 benefits
-
Scientific Director
-
£70, 000 - £85, 000
Subscribe to our email news alerts
PMHub
Consulting at McCann Health
We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...
Latest intelligence
- Creativity in a complex landscape: a pharma perspective
- lue Latitude Health interviewed Mohamed Helal, Marketing Lead for Immunology IBVT at EMEA level for Janssen, to find out his view what an exceptional creative campaign looks like when working...
- Keeping it real
- Virtual and augmented realities are helping to shape the future possibilities for healthcare...
- Perfecting the pharmaceutical pipeline with AI
- How AI can transform the way we identify and validate research...
Quick links
Infographics
